Implenomics, 8 The Green, Suite # 6172, Dover, DE, 19901, USA.
Centers for Disease Control and Prevention, Atlanta, GA, USA.
Cancer Causes Control. 2024 Nov;35(11):1467-1476. doi: 10.1007/s10552-024-01898-w. Epub 2024 Aug 6.
We present findings from an assessment of award recipients' partners from the Centers for Disease Control and Prevention's Colorectal Cancer Control Program (CRCCP). We describe partners' processes of identifying and tracking patients undergoing stool-based screening.
We analyzed data from eight CRCCP award recipients purposively sampled and their partner health systems from 2019 to 2023. The data included number of stool-based tests distributed and returned; abnormal findings; referrals and completion of follow-up colonoscopies; and colonoscopy findings. We also report on strategies to improve tracking of stool-based tests and facilitation of follow-up colonoscopies.
Five of eight CRCCP award recipients reported that all or some partner health systems were able to report stool test return rates. Six had health systems that were able to report abnormal stool test findings. Two reported that health systems could track time to follow-up colonoscopy completion from date of referral, while four could report colonoscopy completion but not the timeframe. Follow-up colonoscopy completion varied substantially from 24.2 to 75.5% (average of 47.9%). Strategies to improve identifying and tracking screening focused mainly on the use of electronic medical records; strategies to facilitate follow-up colonoscopy were multi-level.
Health systems vary in their ability to track steps in the stool-based screening process and few health systems can track time to completion of follow-up colonoscopy. Longer time intervals can result in more advanced disease. CRCCP-associated health systems participating in this study could support the implementation of multicomponent strategies at the individual, provider, and health system levels to improve tracking and completion of follow-up colonoscopy.
我们介绍了美国疾病控制与预防中心（CDC）结直肠癌控制计划（CRCCP）对获奖者伴侣的评估结果。我们描述了伴侣识别和跟踪接受粪便筛查的患者的过程。
我们分析了 2019 年至 2023 年期间从 8 名 CRCCP 获奖者和他们的合作伙伴健康系统中有意抽取的数据。这些数据包括分发和返回的粪便检测数量、异常发现、转诊和完成随访结肠镜检查的情况以及结肠镜检查的结果。我们还报告了改善粪便检测跟踪和促进后续结肠镜检查的策略。
8 名 CRCCP 获奖者中有 5 名报告说，所有或部分合作伙伴健康系统能够报告粪便检测的返回率。6 个系统能够报告异常粪便检测结果。2 个系统能够跟踪从转诊日期到完成随访结肠镜检查的时间，而 4 个系统能够报告结肠镜检查的完成情况，但不能报告时间框架。随访结肠镜检查的完成率差异很大，从 24.2%到 75.5%（平均为 47.9%）。改善识别和跟踪筛查的策略主要集中在使用电子病历上；促进后续结肠镜检查的策略是多层次的。
健康系统在跟踪粪便筛查过程中的步骤的能力上存在差异，很少有健康系统能够跟踪完成后续结肠镜检查的时间。较长的时间间隔可能导致疾病更严重。参与本研究的 CRCCP 相关健康系统可以支持在个人、提供者和健康系统层面实施多组分策略，以改善跟踪和完成后续结肠镜检查。
